HighTower Advisors
BNTX icon

HighTower Advisors’s BioNTech BNTX Stock Holding History

HighTower Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.8M Sell
19,358
-1,627
-8% -$153K ﹤0.01% 1841
2026
Q1 		$1.87M Sell
20,985
-249
-1% -$25.6K ﹤0.01% 1761
2025
Q4 		$2.02M Buy
21,234
+4,971
+31% +$501K ﹤0.01% 1660
2025
Q3 		$1.6M Buy
16,263
+611
+4% +$65.3K ﹤0.01% 1775
2025
Q2 		$1.67M Sell
15,652
-425
-3% -$42.9K ﹤0.01% 1669
2025
Q1 		$1.46M Buy
16,077
+5,079
+46% +$569K ﹤0.01% 1717
2024
Q4 		$1.25M Sell
10,998
-2,562
-19% -$292K ﹤0.01% 1813
2024
Q3 		$1.61M Sell
13,560
-800
-6% -$73.5K ﹤0.01% 1639
2024
Q2 		$1.15M Sell
14,360
-3,732
-21% -$341K ﹤0.01% 1767
2024
Q1 		$1.66M Buy
18,092
+271
+2% +$26K ﹤0.01% 1522
2023
Q4 		$1.9M Buy
17,821
+7,957
+81% +$802K ﹤0.01% 1463
2023
Q3 		$1.09M Sell
9,864
-7,421
-43% -$821K ﹤0.01% 1722
2023
Q2 		$1.89M Buy
17,285
+2,358
+16% +$265K ﹤0.01% 1386
2023
Q1 		$1.85M Buy
14,927
+8,472
+131% +$1.16M ﹤0.01% 1330
2022
Q4 		$973K Buy
6,455
+903
+16% +$139K ﹤0.01% 1692
2022
Q3 		$744K Sell
5,552
-635
-10% -$97.1K ﹤0.01% 1784
2022
Q2 		$924K Sell
6,187
-2
-0% -$306 ﹤0.01% 1686
2022
Q1 		$1.06M Sell
6,189
-10,979
-64% -$1.84M ﹤0.01% 1725
2021
Q4 		$4.43M Sell
17,168
-2,749
-14% -$753K 0.01% 965
2021
Q3 		$5.44M Buy
19,917
+18,939
+1,937% +$6.02M 0.01% 789
2021
Q2 		$218K Sell
978
-1,403
-59% -$265K ﹤0.01% 2604
2021
Q1 		$259K Buy
+2,381
New +$253K ﹤0.01% 2399
2020
Q4 		– Sell
-5,958
Closed -$412K – 2621
2020
Q3 		$412K Buy
5,958
+154
+3% +$11K ﹤0.01% 1662
2020
Q2 		$387K Buy
+5,804
New +$290K ﹤0.01% 1585

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

HighTower Advisors's BNTX Position: Q2 2026 in Review

HighTower Advisors reduced its BioNTech (BNTX) stake by 7.8% in Q2 2026, selling an estimated $153K and leaving 19,358 shares worth $1.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1841.

HighTower Advisors first reported a position in BNTX in Q2 2020 and has held it in 24 quarters since. The position peaked at $5.44M in Q3 2021. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • HighTower Advisors held 19,358 shares of BioNTech worth $1.8M as of Q2 2026.
  • HighTower Advisors sold 1,627 BioNTech shares in Q2 2026, an estimated $153K.
  • BioNTech made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #1841 holding.
  • HighTower Advisors first reported a position in BioNTech in Q2 2020 and has held it in 24 quarters since.
  • HighTower Advisors's BioNTech position peaked at $5.44M in Q3 2021.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.